Saying that a stock with four critical, company-making/ruining inflection points coming up in the next three months is a long term hold makes no investment sense.
Is it a long term hold if we don't get aGVHD approval before a randomised trial, and the ARDS, CHF and LBP trials all fail to meet their endpoints? Surely not.
Saying "I'm holding through the ups and downs to see if the company proves its technology and has a long term future" would be quite a different matter.
Updated Broker Report: Bel Potter, page-95
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |